Synthetic Biologics Names Dr. Mark Pimentel Chairman of IBS Advisory Board

Synthetic Biologics appointed gastroenterologist Mark Pimentel, MD, chairman of its new irritable bowel syndrome clinical advisory board.

Advertisement

The advisory board will serve to support the development of the company’s constipation-predominant IBS program. Dr. Pimentel led the team whose discoveries form the foundation of the C-IBS program.

Dr. Pimentel is an associate professor of medicine at Cedars-Sinai Medical Center in Los Angles.

More Articles on Gastroenterology:
CO2 Insufflation vs. Air Insufflation in Enteroscopy
The Best Opportunities for Quality Improvement Projects in Gastroenterology
Are More Gastroenterologists Participating in ACOs?

Advertisement

Next Up in GI & Endoscopy

  • While gastroenterology has historically been a male-dominated specialty, a growing number of women are driving innovation across clinical care, research…

  • Gastroenterologists face rising clinical and operational obstacles as the GI diseases become more prevalent in the U.S. population and reimbursement…

Advertisement

Comments are closed.